Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Kinetic Resolution. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN115043704A reveals a novel Rh-catalyzed kinetic resolution for high-purity gem-difluoro cyclopropane intermediates, offering significant supply chain and cost advantages.
Patent CN101381387B reveals a stereoselective method for Gemcitabine HCl. This report analyzes cost reduction and supply chain reliability for pharmaceutical manufacturers.
Patent CN103396429B reveals enzymatic synthesis of silicon chiral centers. Achieve >99% ee with mild conditions. Reliable supplier for cost reduction in fine chemical manufacturing.
Novel enzymatic route for amino alcohol intermediates reduces waste and improves chirality. Reliable supply chain partner for scalable pharmaceutical manufacturing.
Patent CN104711313A details enzymatic resolution for eldecalcitol intermediates. This method ensures high purity and cost reduction in pharmaceutical intermediate manufacturing.
Patent CN113979975A details a metal-free chiral phosphoric acid catalyzed kinetic resolution for high-purity pharmaceutical intermediates, offering significant cost reduction and supply chain reliability.
Discover a novel dynamic resolution method for alpha-substituted-2-aminoacetamides achieving 98% yield. Ideal for pharmaceutical and agrochemical intermediate manufacturing.
Novel enzymatic route for posaconazole intermediate improves yield and purity. Cost-effective manufacturing solution for antifungal API supply chains.
Patent CN108192932B details a mild enzymatic route for chiral alcohols, offering high ee values and scalable production for pharmaceutical intermediates.
Patent CN113087691A details a Pd-catalyzed kinetic resolution for chiral aryl tertiary alcohols. Discover cost-effective routes for high-purity pharmaceutical intermediates.
Discover efficient rhodium-catalyzed synthesis of planar chiral metallocenes. Enhance supply chain reliability and reduce manufacturing costs for high-purity intermediates.
Discover the enzymatic synthesis route for Nilaparib intermediates described in CN111072550A. Achieve high purity and cost efficiency in API manufacturing with our advanced catalytic technologies.
Advanced lipase CALB mutant technology enables high-purity pharmaceutical intermediates manufacturing with reduced costs and enhanced supply chain reliability for global buyers.
Patent CN105063161B reveals high-purity R-1-aminoindane production. Offers cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN116024282B details enzymatic dynamic kinetic resolution for high purity S nornicotine offering cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN101248037A reveals organocatalytic kinetic resolution for beta-amino acids, offering cost reduction and scalable manufacturing for pharmaceutical intermediates.
Patent CN104805148A details a novel enzymatic route for (1R,2S)-N-pyrrolidyl norephedrine. This method eliminates controlled precursors, offering significant cost and supply chain advantages for API manufacturers.
Patent CN111778229B reveals high-efficiency hydrolase mutants for >99% ee production. Ideal for reliable pharma intermediate supply chains.
Patent CN105063162A reveals dynamic kinetic resolution for high-purity chiral intermediates. Achieve substantial cost reduction and supply chain reliability in pharmaceutical manufacturing processes.
Patent CN114835541A details a Pd-catalyzed method for high-yield chiral allenoic acids. Offers superior atom economy and scalability for pharmaceutical intermediate manufacturing.